X0306 4 2019-04-29 0000313616 DANAHER CORP /DE/ DHR 0001754423 McGrew Matthew 2200 PENNSYLVANIA AVENUE, NW SUITE 800W WASHINGTON DC 20037 0 1 0 0 EVP & Chief Financial Officer Common Stock 2019-04-29 4 S 0 5020 131.016 D 27534 D Common Stock 2019-04-29 4 M 0 8542 37.51 A 36076 D Common Stock 2019-04-29 4 S 0 8542 130.849 D 27534 D Common Stock 2019-04-29 4 M 0 9176 28.23 D 36710 D Common Stock 2019-04-29 4 S 0 9176 130.865 D 27534 D Common Stock 8707.619 I By 401K Employee Stock Option (Right to Buy) 37.51 2019-04-29 4 M 0 8542 0 D 2021-02-23 Common Stock 8542 0 D Employee Stock Option (Right to Buy) 28.23 2019-04-29 4 M 0 9176 0 D 2020-02-23 Common Stock 9176 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.95 to $131.16, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.74 to $130.98, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.75 to $130.96, inclusive. One half of the options granted become exercisable on each of the fourth and fifth anniversaries of the grant date, which is February 23, 2011. One half of the options granted become exercisable on each of the fourth and fifth anniversaries of the grant date, which is February 23, 2010. James F. O'Reilly, attorney-in-fact for Matthew McGrew 2019-04-30